Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine

Overview of attention for article published in EJNMMI Research, November 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TA…

Application WO-2020180756-A1

World Intellectual Property Organisation (WIPO)